Half-Year 2022 Financial and Clinical Trials Update

Diabetes Care CER-Constant Exchange Rates CHFbn 1.0 0.8 0.6 0.4 0.2 0.0 HY 2020 HY 2021 Blood Glucose Monitoring 2022 vs. 2021 CER growth -5% HY 2022 Other +18% -7% Roche 193

View entire presentation